Translation of Anxiety Treatment to Youth with Autism Spectrum Disorders

被引:9
作者
Selles, Robert R. [1 ,2 ]
Storch, Eric A. [1 ,2 ,3 ,4 ]
机构
[1] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA
[2] Univ S Florida, Dept Pediat, Tampa, FL 33620 USA
[3] Univ S Florida, Dept Psychiat, Tampa, FL 33620 USA
[4] Univ S Florida, Dept Behav Neurosci, Tampa, FL 33620 USA
关键词
Anxiety; Autism spectrum disorders; Psychotherapy; Psychopharmacology; Cognitive-behavioral therapy; COGNITIVE-BEHAVIORAL THERAPY; PERVASIVE DEVELOPMENTAL DISORDERS; HIGH-FUNCTIONING AUTISM; OBSESSIVE-COMPULSIVE DISORDER; FOLLOW-UP; PSYCHIATRIC-DISORDERS; REPETITIVE BEHAVIOR; ASPERGERS-SYNDROME; DOUBLE-BLIND; CHILDREN;
D O I
10.1007/s10826-012-9593-1
中图分类号
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号
1204 ;
摘要
Clinically significant anxiety affects many youth with autism spectrum disorders (ASD) and is associated with a number of functional consequences. Building from treatment approaches of anxiety in typically developing populations, pharmacological and psychotherapeutic approaches to treating anxiety in ASD are being increasingly examined. Despite being commonly prescribed, there is limited empirical support beyond open trials and case series at present for the use of antidepressants or anxiolytics in the treatment of anxiety for youth with ASD. A modest body of evidence exists supporting the application of a modified form of cognitive-behavioral therapy, with associated reductions in anxiety and some core autism improvements. Further research, refinement and replication is needed to establish the efficacy of treatment approaches for anxiety in youth with ASD, what treatment component(s) are most appropriate for which patients, what factors may play an integral role in treatment outcomes, and whether treatments result in durable and generalizable gains.
引用
收藏
页码:405 / 413
页数:9
相关论文
共 91 条
[31]   Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder [J].
Geller, DA ;
Biederman, J ;
Stewart, SE ;
Mullin, B ;
Martin, A ;
Spencer, T ;
Faraone, SV .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (11) :1919-1928
[32]   Depression in persons with autism: Implications for research and clinical care [J].
Ghaziuddin, M ;
Ghaziuddin, N ;
Greden, J .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2002, 32 (04) :299-306
[33]   Anxiety in high-functioning children with autism [J].
Gillott, A ;
Furniss, F ;
Walter, A .
AUTISM, 2001, 5 (03) :277-286
[34]  
Green S. A., 2011, J AUTISM DEV DISORDE
[35]   Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors: A chart review [J].
Henry, CA ;
Steingard, R ;
Venter, J ;
Guptill, J ;
Halpern, EF ;
Bauman, M .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (1-2) :187-195
[36]   A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism [J].
Hollander, E ;
Phillips, A ;
Chaplin, W ;
Zagursky, K ;
Novotny, S ;
Wasserman, S ;
Iyengar, R .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) :582-589
[37]   The effects of social interactive training on early social communicative skills of children with autism [J].
Hwang, B ;
Hughes, C .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2000, 30 (04) :331-343
[38]  
Kanner L, 1943, NERV CHILD, V2, P217
[39]   Autism spectrum symptomatology in children: The impact of family and peer relationships [J].
Kelly, Adrian B. ;
Garnett, Michelle S. ;
Attwood, Tony ;
Peterson, Candida .
JOURNAL OF ABNORMAL CHILD PSYCHOLOGY, 2008, 36 (07) :1069-1081
[40]   Child anxiety treatment: Outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up [J].
Kendall, PC ;
Safford, S ;
Flannery-Schroeder, E ;
Webb, A .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2004, 72 (02) :276-287